Suppressive Effect of Sarpogrelate Hydrochloride on Respiratory Failure and Right Ventricular Failure with Pulmonary Hypertension in Patients with Systemic Sclerosis

Author： Kato S   Kishiro I   Machida M   Fuse D   Yoshida T   Kaneko N  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.28, Iss.6, 2000-11, pp. : 258-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling

By  

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4780-4795

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of ETAReceptor Antagonist on Pulmonary Hypertension and Vascular Reactivity in Rats With Congestive Heart Failure

By Lucas M.   Jasmin J.F.   Dupuis J.  

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 4, 2001-08 ,pp. : 307-314

Academic Press

Access to resources Recommend Favorite

Bosentan: A Review of its Use in Pulmonary Arterial Hypertension and Systemic Sclerosis

By Oldfield Vicki   Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 189-208

Adis International

Access to resources Recommend Favorite

Exercise‐induced pulmonary hypertension associated with systemic sclerosis: Four distinct entities

By  

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3741-3750

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1457-1464

Bentham Science Publishers

Access to resources Recommend Favorite